Replies to post #15242 on Momenta Pharmaceuticals, Inc. (MNTA)

[jbog]

Curious IMS glatopa Nrx % is much higher than symptony. Is that generally the case?.

Not normally. I'd hoped we'd see a formulary forced uptick.